Lipofundin MCT/LCT 20%

B. Braun · Parenteral nutrition

20% lipid emulsion with a mixture of MCT and LCT.

Composition per 1,000 ml

  • Fat100%

Share of energy from macronutrients · protein and carbohydrates 4 kcal/g, fat 9 kcal/g

Energy
1,935 kcal · 1.94 kcal/ml
Protein
0 g
Carbohydrates
0 g
Fat
200 g
Osmolarity
380 mOsm/l

Values are normalised per 1,000 ml, not per pack.

Pack sizes

100 ml, 250 ml, 500 ml bottle

Route of administration

Peripheral or central vein

Special indications

Standard product without a special indication – used within the general indication for nutrition.

When parenteral nutrition is indicated

Contraindications

  • Hypersensitivity to any component or to egg, soya or peanut protein
  • Severe hyperlipidaemia
  • Severe blood coagulation disorders
  • Severe hepatic insufficiency
  • Intrahepatic cholestasis
  • Severe renal insufficiency without haemofiltration or dialysis
  • Acute thromboembolic events
  • Fat embolism
  • Worsening haemorrhagic diatheses
  • Metabolic acidosis
  • Unstable circulation with vital threat (e.g. collapse, shock)
  • Unstable metabolic condition (e.g. severe post-aggression syndrome, severe sepsis, coma of unknown origin)
  • Acute myocardial infarction or stroke
  • Uncorrected disorders of fluid and electrolyte balance (e.g. hypokalaemia, hypotonic dehydration)
  • Decompensated cardiac insufficiency
  • Acute pulmonary oedema

Condensed from the contraindications in the official product document. The full text and warnings are in the document.

Official document

Lipofundin MCT/LCT 20 %, emulsion for infusionSmPC – summary of product characteristics · Source: emcOpens in a new tab
  • Not registered in Slovakia.

Document last checked on 16 September 2026. Composition is based on SmPCs and official manufacturer catalogues and may change. Always verify the current SmPC or manufacturer datasheet before administration.

Report an error in the data